AstraZeneca’s Saphnelo (anifrolumab) has received a positive recommendation from the Committee for Medicinal Products for Human Use (CHMP) for approval in the European Union as a self-administered, ...

The evolution of immunotherapy, featuring CAR-T cells and senolytics, highlights potential in cancer treatment and challenges ...

AstraZeneca has announced that Saphnelo (anifrolumab) has been recommended for approval in the European Union (EU) as a ...

Lung cancer and melanoma patients immunized with this formula doubled their chances of surviving three years, according to a ...

Millions of Americans take antidepressants. And like all medication they come with side effects. Researchers studied 30 ...

A new large-scale analysis found that the short-term cardiovascular and metabolic side effects of antidepressants vary widely ...

In the study, published Tuesday in the journal The Lancet, researchers analyzed more than 58,000 participants to compare 30 ...

Antidepressants can be very effective, but they also come with side effects that vary from one drug to the next, supporting ...

Reviewers viewed the targeting of TFAM as innovative and the study's conclusions as potentially important (especially the effects on inflammation). However, the lack of evidence for a direct effect of ...

Further validating the results, University of Florida researchers found that tying cancer immunotherapies with COVID-targeted ...

Inhaled corticosteroids pose long-term risks in COPD management, prompting careful screening and potential de-escalation ...